Rallybio Corporation Common Stock RLYB
$16.14
+1.13%
at last close
Financials (TTM)
- Revenue
- $858,000
- Net Income
- $-7,817,000
- Net Margin
- -911.07%
- Return on Equity
- -15.55%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 1.70
- Price / Sales
- 99.83
Over the trailing twelve months, Rallybio Corporation Common Stock generated revenue of $858,000 and net income of $-7,817,000, a net margin of -911.07%.
At the last closing price of $16.14, RLYB trades at 99.83 times sales, with a market capitalization of $85.65 million.
Key Stats
- Last Close
- $16.14
- Market Cap
- $85.65 million
- 52-Week Range
- $2.55 – $17.57
- Average Volume
- 40K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.